Actualités XOMA Royalty Corporation - XOMA | Actions NASDAQ

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation PR Newswire NEW YORK, April 27, 2026 NEW YORK...

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Transaction expands Ligand’s royalty portfolio to more than 200 assets and adds seven new commercial products...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today...

XOMA shares climb after Q4 results top forecasts on strong royalty income

XOMA Royalty Corporation (NASDAQ:XOMA) posted fourth-quarter results that came in ahead of analyst expectations, supported by higher royalty...

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

Portfolio receipts: • Achieved over $50 million of cash receipts, including $33.6 million in royalties and...

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

EMERYVILLE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech...

XOMA Royalty to Present at Investor Conferences in March

EMERYVILLE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech...

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

EMERYVILLE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty”...

XOMA Royalty Announces CFO Transition

EMERYVILLE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq:...

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

– Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech...

XOMA Royalty Enters into Agreement to Acquire Generation Bio

- Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with Moderna...

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc

EMERYVILLE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq:...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

XOMA Royalty Corporation (XOMA)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

XOMA Royalty Corporation (XOMA) Actualités

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA shares climb after Q4 results top forecasts on strong royalty income

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

XOMA Royalty to Present at Investor Conferences in March

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

XOMA Royalty Announces CFO Transition

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Enters into Agreement to Acquire Generation Bio

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

XOMA Royalty Corporation (XOMA)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

XOMA Royalty Corporation (XOMA) Actualités

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA shares climb after Q4 results top forecasts on strong royalty income

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

XOMA Royalty to Present at Investor Conferences in March

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

XOMA Royalty Announces CFO Transition

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Enters into Agreement to Acquire Generation Bio

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités